Charts

News

11 Apr, 2024
Gainers Ontrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands ...
10 Apr, 2024
Gainers Rallybio (NASDAQ:RLYB) shares rose 31.9% to $2.15 during Wednesday's after-market session. The company's market cap stands at ...
23 Mar, 2024
BIOLASE, Inc. (NASDAQ:BIOL) Q4 2023 Earnings Call Transcript March 21, 2024 BIOLASE, Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.56. BIOL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the BIOLASE Fourth […]
22 Mar, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth ...
Gainers IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 91.5% to $2.47 during Friday's regular session. The market value of their ...
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to ...
15:13
FinancialContent
BIOLASE, Inc.(NASDAQ:BIOL) shares are surging after the company reported better-than-expectedfourth-quarter FY23 EPS ...
U.S. stocks traded slightly lower this morning. Following the market opening Friday, the Dow traded down 0.06% to 39,758.88 while the ...
Gainers Biolase (NASDAQ:BIOL) shares moved upwards by 61.5% to $0.24 during Friday's pre-market session. The market value of their ...
Shares of FedEx Corporation (NYSE: FDX) rose sharply in today’s pre-market trading after the company reported ...
10:19
Yahoo! Finance
Q4 2023 BIOLASE Inc Earnings Call
InvestorPlace - Stock Market News, Stock Advice & Trading Tips BIOL stock results show that Biolase beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. The post BIOL Stock Earnings: Biolase Beats EPS, Misses Revenue for Q4 2023 appeared first on InvestorPlace. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million. Do this now.
21 Mar, 2024
20:20
FinancialContent
Biolase (NASDAQ:BIOL) reported its Q4 earnings results on Thursday, March 21, 2024 at 04:05 PM. Here's what investors need to know about ...
LAKE FOREST, CA / ACCESSWIRE / March 21, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, who previously announced its preliminary financial results for the fourth quarter and full year ended December 31, 2023, today reported its financial results for the quarter and full year.
10:15
FinancialContent
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per ...
20 Mar, 2024
21:35
Seeking Alpha
17:00
FinancialContent
Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2024-03-21. Here's what investors need to know ...
14 Mar, 2024
LAKE FOREST, CA / ACCESSWIRE / March 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release fourth quarter and full year 2023 financial and operating results on Thursday, March 21, 2024, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
01 Mar, 2024
Gainers Ainos (NASDAQ:AIMD) stock moved upwards by 54.3% to $1.62 during Friday's after-market session. The company's market cap stands ...
22 Feb, 2024
Waterlase iPlus Premier Edition™ is being unveiled at the Chicago Midwinter Meeting 2024
20 Feb, 2024
LAKE FOREST, CA / ACCESSWIRE / February 20, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, remains committed to expanding its educational offerings through its web portal, enabling dental clinicians to elevate their standard of dental care and improve patient outcomes through laser technology. "Let's Talk Dental," a free webinar series focused on a variety of topics covering all dental disciplines, kicked off the year with a webinar on January 18, 2024, hosted by Dr. Paul Chang, a periodontist and prosthodontist with a private practice in McKinney, Texas. Dr. Chang lectured on the clinical benefits of using the Waterlase all-tissue dental laser for extractions and immediate implant placement.
15 Feb, 2024
LAKE FOREST, CA / ACCESSWIRE / February 15, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced the closing of its public offering of 16,000,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant to purchase one share of common stock), one Class A Warrant to purchase one share of common stock, and one Class B Warrant to purchase one share of common stock. Each unit was sold at an effective public offering price of $0.44. The Class A warrants are immediately exercisable at a price of $0.66 per share and expire five years from the date of issuance. The Class B warrants will be exercisable on the date of stockholder approval at a price of $0.748 per share and expire five years from the date of such stockholder approval. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants were only purchasable together in this offering, but were issued separately and were immediately separable upon issuance.
14 Feb, 2024
LAKE FOREST, CA / ACCESSWIRE / February 14, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it received notice from the Staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that the Staff has determined to grant the Company an extension of time to regain compliance with Listing Rule 5550(b) (the "Rule"). The Rule requires a minimum of $2,500,000 stockholders' equity, $35,000,000 market value of listed securities, or $500,000 net income from continuing operations.
13 Feb, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index dipping over 700 points on Tuesday. The Dow traded down ...
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed ...
Gainers FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) shares rose 29.1% to $9.55 during Tuesday's regular session. Candel ...
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling over 1% on Tuesday. The Dow traded down 1.05% to ...
U.S. stocks traded lower this morning, with the Dow Jones index falling over 300 points on Tuesday. Following the market opening ...
LAKE FOREST, CA / ACCESSWIRE / February 13, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced the pricing of its public offering of 16,000,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant to purchase one share of common stock), one Class A Warrant to purchase one share of common stock, and one Class B Warrant to purchase one share of common stock. Each unit is being sold at an effective public offering price of $0.44. The Class A warrants will be immediately exercisable at a price of $0.66 per share and will expire five years from the date of issuance. The Class B warrants will be exercisable on the date of stockholder approval at a price of $0.748 per share and will expire five years from the date of such stockholder approval. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying warrants can only be purchased together in this offering, but will be issued separately and will be immediately separable upon issuance.
09 Feb, 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum ...
07 Feb, 2024
Gainers ThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 39.0% to $0.86 during Wednesday's regular session. The market value ...
29 Jan, 2024
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced preliminary unaudited revenue results for 2023 based on currently available information and expects to report year-over-year growth as it continues to generate interest among dental practitioners for its industry leading lasers. The Company is also taking additional steps to optimize operations and believes its revenue-generating strategies and prudent management of its expenses will enable it to achieve its sales and pr
08 Jan, 2024
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, has experienced growing demand for its robust educational offering and as a result has increased the number of dental laser courses planned for the first quarter of 2024. The full list of both in-person and virtual course options offered can be found through BIOLASE'S education web portal at Education.Biolase.com. Education.Biolase.com offers tailored education pathways through the Waterlase Academy and Epic Diode Academy.
03 Jan, 2024
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2023 honor by the Inland News Group. This award is in addition to the Top Workplaces 2023 honor from the Orange County Register, previously announced. The awards are based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The confidential survey uniquely measures 15 culture drivers
02 Jan, 2024
Gainers First Wave BioPharma (NASDAQ:FWBI) shares increased by 40.8% to $5.38 during Tuesday's after-market session. The company's ...
26 Dec, 2023
14 Dec, 2023
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been awarded a Top Workplaces 2023 honor by Orange County Register Top Workplaces. The award is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage LLC. The confidential survey uniquely measures 15 culture drivers that are critical to success, including alignment, execution, and connection.
12 Dec, 2023
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the Waterlase iPlus All Tissue laser conducted by six leading U.S. dentists. The trial, led by an independent consultant, evaluated both the potential return on investment (ROI) and clinical adoption of BIOLASE's leading technology. The trial revealed unanimous doctor satisfaction with the performance and desire to recommend the purchase to others. This represe
08 Dec, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
06 Dec, 2023
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $1.4 million of its common stock and pre-funded warrants in a registered direct offering and warrants to purchase common stock in a concurrent private placement, priced at-the-market under Nasdaq rules. The combined effective purchase price for one share of common stock (or pre-funded warrant in l
Gainers Phio Pharma (NASDAQ:PHIO) stock increased by 33.9% to $1.5 during Wednesday's pre-market session. The company's market cap ...
04 Dec, 2023
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of ...
10 Nov, 2023
Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial ...
Shares of Direct Digital Holdings, Inc. (NASDAQ: DRCT) rose sharply in pre-market trading after the company reported ...
09 Nov, 2023
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the third quarter ended September 30, 2023.
08 Nov, 2023
22:35
Seeking Alpha
19:02
FinancialContent
Biolase (NASDAQ:BIOL) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here's what investors need to know ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Pre-market stock movers are a hot topic on Wednesday and we're starting the morning with a breakdown of the biggest ones. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental lasers, today announced groundbreaking findings from a 12-month follow-up to a clinical trial performed at The McGuire Institute™. The findings will be published in the November 2023 issue of the Journal of Periodontology. The pioneering study was designed to meet the stringent American Association of Periodontology Best Evidence Consensus (BEC) standards, and is the first-of-its-kind study to compare BIOLASE's REPAIR® Perio protocol to th
07 Nov, 2023
BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release third quarter 2023 financial and operating results on Thursday, November 9, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
18 Oct, 2023
SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower partners.
18 Sep, 2023
BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the closing of its previously announced underwritten public offering of 75,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series J Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $100.00 per share (the "Series J Convertible Preferred Stock"), and one warrant (the "Warrants") to purchase one-half of one (0.5
15 Sep, 2023
BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 37% to $2.00over the trailing five sessionsafter the company this ...
14 Sep, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Thursday. The Dow ...
Gainers First Wave BioPharma (NASDAQ:FWBI) shares moved upwards by 23.8% to $0.54 during Thursday's regular session. As of 13:30 EST, ...
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for ...
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Thursday. The Dow traded up ...
BIOLASE Inc (NASDAQ: BIOL) shares are trading lower by 38% to $2.03 Thursday morning after the company announced pricing of a $4.5 ...
09 Aug, 2023
21:35
Seeking Alpha
26 Jul, 2023
10 May, 2023
21:35
Seeking Alpha
27 Mar, 2023
21:35
Seeking Alpha
18 Jan, 2023
09 Nov, 2022
22:35
Seeking Alpha

Related Articles